What analysts have to say about CSL (ASX: CSL) shares?

2 min read | January 18, 2024 07:04 PM AEDT | By Team Kalkine Media

Google News:

What analysts have to say about CSL (ASX: CSL) shares? — Image source: © Timonschneider | Megapixl.com

Recent News

Santos (ASX:STO) After the Takeover Collapse: Bargain or Value Trap?

Why Pro Medicus (ASX:PME) Is Leading the Growth Stock Conversation

Is 360 (ASX:360) Amid ASX 200 Revealing Growth’s New Reality?

Why 360 (ASX:360) ASX 200 Is Facing a New Growth Test

Make Kalkine Media
My Trusted Source

Investors who witnessed the meteoric rise of CSL Limited (ASX: CSL) in the early 2020s might find the recent trajectory perplexing. The company, known for its double-digit share price gains, soared from under AU$100 in 2015 to surpass the AU$300 mark by early 2020. However, the narrative took a turn, and CSL shares have been navigating a sideways path ever since.

Current Landscape: A Closer Look

As of now, CSL's share price stands at AU$285.65, reflecting a decline of over 15% from its pre-COVID peak of around AU$340 a share in 2020. Over the past 12 months, the stock has traded within a range of AU$228.65 to AU$314.28, showcasing a pattern of stability.

Experts' Projections: Bullish Outlook for 2024

Despite the recent stagnation, leading brokers such as Citi, UBS, Macquarie, Morgans, and Goldman Sachs are optimistic about CSL's future. Each of these financial experts has assigned buy ratings to the stock, emphasizing their confidence in its potential for growth.

Share Price Targets: A Glimpse into Analyst Predictions

Citi envisions CSL reaching AU$325 within the next 12 months.
Goldman Sachs, slightly more conservative, sets a target of AU$309.
UBS stands as the most bullish with a target of AU$340.
Macquarie and Morgans have targets of AU$321 and AU$328.20, respectively.

Insights from Macquarie: A Key Portfolio Holding

Macquarie views CSL as a key portfolio holding and sector pick, anticipating double-digit recovery in earnings growth. The positive outlook stems from factors such as increased plasma collections, approval of new products, and heightened influenza vaccine uptake amid ongoing concerns about respiratory viruses.

What Lies Ahead in 2024?

While the projected share price targets may not breach CSL's all-time high, investors could still witness substantial gains in the coming year if these predictions materialize. The healthcare giant's performance hinges on various factors, including the execution of strategic decisions and market dynamics.

Conclusion: Anticipation and Optimism

In conclusion, the CSL share price narrative is poised for potential excitement in 2024. Analysts and brokers paint a picture of optimism, expecting a positive trajectory for CSL. Investors are advised to stay tuned for potential breakthroughs and promising gains.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.